In a challenging year for Aclarion, the medical technology company's stock has plummeted to a 52-week low, trading at $4.41. According to InvestingPro data, the company maintains a healthy liquidity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback